Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Acitretin MeSH Descriptor Data 2025


MeSH Heading
Acitretin
Tree Number(s)
D02.455.326.271.665.202.495.050
D02.455.849.131.495.050
D23.767.261.700.050
Unique ID
D017255
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D017255
Scope Note
An oral retinoid effective in the treatment of psoriasis. It is the major metabolite of ETRETINATE with the advantage of a much shorter half-life when compared with etretinate.
Entry Term(s)
13-cis-Acitretin
Acitretin, (Z,E,E,E)-Isomer
Etretin
Isoacitretin
Isoetretin
Neotigason
Ro 10-1670
Ro 13-7652
Ro-10-1670
Ro-13-7652
Soriatane
Pharm Action
Keratolytic Agents
Registry Numbers
LCH760E9T7
0
69427-46-9
Related Numbers
54757-46-9
55079-83-9
69427-46-9
CAS Type 1 Name
2,4,6,8-Nonatetraenoic acid, 9-(4-methoxy-2,3,6-trimethylphenyl)-3,7-dimethyl-, (all-E)-
Previous Indexing
Tretinoin/analogs & derivatives (1977-1992)
Public MeSH Note
93; ACITRETIN was indexed under TRETINOIN/analogs & derivatives 1977-92
Online Note
use ACITRETIN (NM) to search ACITRETIN 1980-92
History Note
93; was ACITRETIN (NM) 1977-91
Date Established
1993/01/01
Date of Entry
1992/05/07
Revision Date
2017/02/24
Acitretin Preferred
13-cis-Acitretin Related
Isoetretin Related
Ro-13-7652 Related
Isoacitretin Related
Soriatane Narrower
Acitretin, (Z,E,E,E)-Isomer Related
Ro 10-1670 Narrower
Neotigason Narrower
page delivered in 0.152s